ES EN
Menu Menú

Beat the Press

Beat the press por Dean Baker

Beat the Press is Dean Baker's commentary on economic reporting. He is a Senior Economist at the Center for Economic and Policy Research (CEPR). To never miss a post, subscribe to a weekly email roundup of Beat the Press. Please also consider supporting the blog on Patreon.

• InequalityLa DesigualdadIntellectual PropertyPropiedad Intelectual

NYT Wants to Talk About Higher Wages, but Doesn’t Want to Talk About the Real Reasons Wages are Low

By Dean BakerDean Baker

November 29, 2020

29 Noviembre 2020

The bigger problem is the assertion that the failure of pay to keep pace with productivity growth over the last four decades is due to higher profits.
The bigger problem is the assertion that the failure of pay to keep pace with productivity growth over the last four decades is due to higher profits.

Read More Leer más Join the discussion Participa en la discusión

• Economic Crisis and RecoveryCrisis económica y recuperación

More Bad News About the Pandemic Recession: Longer Hours

By Dean BakerDean Baker

November 28, 2020

28 Noviembre 2020

One way of dealing with this reduction in employment opportunities is to have shorter work weeks/work years. Unfortunately, it seems we are now headed in the wrong direction.  
One way of dealing with this reduction in employment opportunities is to have shorter work weeks/work years. Unfortunately, it seems we are now headed in the wrong direction.  

Read More Leer más Join the discussion Participa en la discusión

• Economic Crisis and RecoveryCrisis económica y recuperaciónInequalityLa DesigualdadIntellectual PropertyPropiedad Intelectual

Why are the Free Traders All Protectionists? Vaccines and Sharing Knowledge (Fun for Thanksgiving)

By Dean BakerDean Baker

November 25, 2020

25 Noviembre 2020

But the fact remains, protection for manufactured goods is universally derided in outlets like the New York Times, Washington Post, and The Atlantic. Protectionism in the form of patent and copyright monopolies, which is hugely more costly, is never even
But the fact remains, protection for manufactured goods is universally derided in outlets like the New York Times, Washington Post, and The Atlantic. Protectionism in the form of patent and copyright monopolies, which is hugely more costly, is never even

Read More Leer más Join the discussion Participa en la discusión

• InequalityLa DesigualdadIntellectual PropertyPropiedad Intelectual

News for Bill Gates: Capitalism Is Still Capitalism Without Patent Monopolies

By Dean BakerDean Baker

November 23, 2020

23 Noviembre 2020

Gates apparently is not aware that the U.S. government paid for Moderna's research and testing costs for its vaccines.
Gates apparently is not aware that the U.S. government paid for Moderna's research and testing costs for its vaccines.

Read More Leer más Join the discussion Participa en la discusión

• Budget

Fighting Disinformation: Maybe Reporters Can Try Putting Big Budget Numbers in Contexts that Make Them Understandable

By Dean BakerDean Baker

November 22, 2020

22 Noviembre 2020

If reporters are really interested in countering the nonsense thrown out by the right, writing big numbers in ways that actually provide information to their audience would be a big help.
If reporters are really interested in countering the nonsense thrown out by the right, writing big numbers in ways that actually provide information to their audience would be a big help.

Read More Leer más Join the discussion Participa en la discusión

• COVID-19CoronavirusIntellectual PropertyPropiedad Intelectual

How Many Lives Would Have Been Saved if We Had Collaborated on Vaccines With China?

By Dean BakerDean Baker

November 21, 2020

21 Noviembre 2020

It makes sense to cooperate in areas of mutual benefit. Developing vaccines and treatments against the pandemic would have been an obvious example.
It makes sense to cooperate in areas of mutual benefit. Developing vaccines and treatments against the pandemic would have been an obvious example.

Read More Leer más Join the discussion Participa en la discusión

• COVID-19CoronavirusIntellectual PropertyPropiedad Intelectual

Moderna Vaccine Follows Pfizer with Very Strong Results on Effectiveness: What This Means

By Dean BakerDean Baker

November 19, 2020

19 Noviembre 2020

Moderna’s success also demonstrates an important economic point: Having the government pay a company to develop a vaccine is not the same thing as throwing money in the toilet.
Moderna’s success also demonstrates an important economic point: Having the government pay a company to develop a vaccine is not the same thing as throwing money in the toilet.

Read More Leer más Join the discussion Participa en la discusión

• Economic Crisis and RecoveryCrisis económica y recuperación

The Krugman Boom: Don’t Bank on It

By Dean BakerDean Baker

November 19, 2020

19 Noviembre 2020

While I have not been one of the doomsayers predicting economic collapse, I can’t be as optimistic as Paul on this one.
While I have not been one of the doomsayers predicting economic collapse, I can’t be as optimistic as Paul on this one.

Read More Leer más Join the discussion Participa en la discusión

• Globalization and TradeGlobalización y comercioIntellectual PropertyPropiedad Intelectual

“Protecting Intellectual Property” Against China Means Redistributing Income Upward

By Dean BakerDean Baker

November 16, 2020

16 Noviembre 2020

Stronger and longer patent and copyright protections have redistributed enormous amounts of income upward over the past four decades.
Stronger and longer patent and copyright protections have redistributed enormous amounts of income upward over the past four decades.

Read More Leer más Join the discussion Participa en la discusión

• COVID-19CoronavirusIntellectual PropertyPropiedad Intelectual

Lowering the Bar on Success: Megan McArdle on Drug Development

By Dean BakerDean Baker

November 12, 2020

12 Noviembre 2020

We want to know if the way we finance drug research is the best way, not just that it can lead to successful drugs and vaccines.
We want to know if the way we finance drug research is the best way, not just that it can lead to successful drugs and vaccines.

Read More Leer más Join the discussion Participa en la discusión

Want to search in the archives?

¿Quieres buscar en los archivos?

Click Here Haga clic aquí